![](/img/cover-not-exists.png)
Attainment of treat-to-target endpoints in SLE patients with high disease activity in the atacicept phase 2b ADDRESS II study
Morand, Eric F, Isenberg, David A, Wallace, Daniel J, Kao, Amy H, Vazquez-Mateo, Cristina, Chang, Peter, Pudota, Kishore, Aranow, Cynthia, Merrill, Joan TJournal:
Rheumatology
DOI:
10.1093/rheumatology/keaa029
Date:
February, 2020
File:
PDF, 599 KB
2020